Thiacetazone in pulmonary tuberculosis with reference to its clinical intolerance
Sen, P.K.; Sen, N.N.; Saha, J.R.; Paul, N.B.; Prodhan, P.K.
Indian Journal of Medical Research 58(8): 1002-1011
1970
ISSN/ISBN: 0019-5340 PMID: 4099710 Document Number: 23348
Document emailed within 1 workday
Related Documents
Alimov, S.A.; Kazakov, K.S.; Motorina, V.V.; Prokof'eva, V.V.; Chernik, M.B. 1970: Blood serum enzymes during drug intolerance in pulmonary tuberculosis Voprosy Meditsinskoi Khimii 16(6): 583-587Spesivtsev, O.G.; Prosvetov, I.V.; Gal'chanskaia, L.D. 1987: Effectiveness of hyposensitization in drug intolerance in patients with pulmonary tuberculosis Problemy Tuberkuleza 12: 30-33
Owsiński, J. 1973: Case of Addison's disease in the course of pulmonary tuberculosis as a cause of intolerance to antitubercular agents Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 41(10): 1097-1098
Chintu, C.; Luo, C.; Bhat, G.; Raviglione, M.; DuPont, H.; Zumla, A. 1993: Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I Archives of Disease in Childhood 68(5): 665-668
Ueda, T. 1973: Vectorcardiogram in pulmonary tuberculosis with reference to P-Vector loop Nihon Kyobu Shikkan Gakkai Zasshi 11(8): 461-472
Grosset, J.; Benhassine, M. 1970: Thiacetazone (Tb-1): recent experimental and clinical data Bibliotheca Tuberculosea 26: 107-153
Korotaev, G.A.; Kozulitsyna, T.I.; Tret'iakova, E.A.; Mamed'iarova, F.A. 1986: Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis Problemy Tuberkuleza 7: 32-36
van Gorkom, J.; Kibuga, D.K. 1996: Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 77(1): 30-36
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Afonja, A.O.; Labode, M.O.; Edet, E.G. 1973: Early yield of pulmonary tuberculosis among household contacts of known cases of open pulmonary tuberculosis in Lagos East African Medical Journal 50(3): 136-139
Jiang, D.; Hu, X.; Li, S.; Julaiti, A.; Xia, Y.; Wang, J.; Wushouer, Q. 2015: Polymorphisms of IL-23 receptor gene are associated with susceptibility to pulmonary tuberculosis and drug-resistant pulmonary tuberculosis Zhonghua Yi Xue Za Zhi 95(20): 1576-1580
Wolf, K. 1994: Clinical aspects of pulmonary tuberculosis Wiener Medizinische Wochenschrift 144(8-9): 146-153
Herbst, W.M.; Schmidt, K.G.; Forssmann, W.G. 1987: Primary pulmonary hypertension in childhood--clinical course and morphologic correlations with particular reference to the endocrine heart Zeitschrift für Kardiologie 76(7): 439-444
Donomae, I.; Fujita, S.; Gomi, J.; Hibino, S.; Horai, Z. 1973: Clinical study of tuberactinomycin-N in pulmonary tuberculosis Kekkaku: 48(10): 473-479
Iwai, K. 1981: Clinical and pathological problems in pulmonary tuberculosis Nihon Kyobu Shikkan Gakkai Zasshi 19(10): 699-706
Sánchez Montón, T.; Martín Luengo, F. 1992: Serodiagnosis in pulmonary tuberculosis. Clinical evaluation Enfermedades Infecciosas y Microbiologia Clinica 10(5): 267-271
Petrunina, M.P. 1987: Clinical x-ray manifestations of focal pulmonary tuberculosis Problemy Tuberkuleza 9: 38-41
Kawabata, S.; Funakoshi, M.; Kameda, K. 1983: A clinical study on the chemotherapy for pulmonary tuberculosis in diabetics Kekkaku: 58(1): 25-31
Nechaeva, O.B. 1994: Characteristics of clinical course of pulmonary tuberculosis in penitentiary population Problemy Tuberkuleza 4: 11-14
Schweisfurth, H.; Link, K. 1995: Clinical studies of the incidence of pulmonary and extrapulmonary tuberculosis Versicherungsmedizin 47(6): 207-212